Mangoceuticals, Inc.
MGRX
$4.91
-$0.37-7.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 133.40K | 163.20K | 214.10K | 244.40K | 245.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 133.40K | 163.20K | 214.10K | 244.40K | 245.20K |
| Cost of Revenue | 50.70K | 93.40K | 66.70K | 101.80K | 100.60K |
| Gross Profit | 82.70K | 69.80K | 147.40K | 142.60K | 144.60K |
| SG&A Expenses | 1.59M | 1.96M | 2.07M | 2.37M | 1.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.64M | 2.29M | 2.30M | 2.11M | 1.79M |
| Operating Income | -1.50M | -2.13M | -2.09M | -1.87M | -1.54M |
| Income Before Tax | -2.00M | -2.39M | -2.37M | -2.57M | -1.80M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.00M | -2.39M | -2.37M | -2.57M | -1.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 500.00 | 300.00 | 0.00 | -- | -- |
| Net Income | -2.00M | -2.39M | -2.37M | -2.57M | -1.80M |
| EBIT | -1.50M | -2.13M | -2.09M | -1.87M | -1.54M |
| EBITDA | -1.50M | -2.13M | -2.08M | -1.86M | -1.54M |
| EPS Basic | -0.99 | -1.37 | -1.56 | -1.96 | -1.70 |
| Normalized Basic EPS | -0.62 | -0.86 | -0.97 | -1.22 | -1.06 |
| EPS Diluted | -0.99 | -1.37 | -1.56 | -1.96 | -1.70 |
| Normalized Diluted EPS | -0.62 | -0.86 | -0.97 | -1.22 | -1.06 |
| Average Basic Shares Outstanding | 2.01M | 1.74M | 1.52M | 1.31M | 1.06M |
| Average Diluted Shares Outstanding | 2.01M | 1.74M | 1.52M | 1.31M | 1.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
